{"schema_version":"secwatch.filing_event.v1","accession":"0001688757-24-000005","form_type":"8-K","ticker":"ESTA","cik":"0001688757","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.120119+00:00","generated_at":"2026-06-07T01:34:54.525883+00:00","sec_items":["1.01","2.02","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Establishment Labs raises $50M via private placement; Q4 rev. $31.4-$31.8M in-line","bullets":["Gross proceeds of $50M from sale of 2M common shares/pre-funded warrants at $25.00 per share.","Preliminary Q4 2023 revenue $31.4M-$31.8M; FY 2023 revenue $165.0M-$165.4M.","Year-end 2023 cash ~$39.1M, down $12.9M from Q3; targeting EBITDA positive in 2024 and cash positive in 2025.","Private placement led by Nantahala Capital and RTW; proceeds for working capital and corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001688757-24-000005","json":"https://secwatch.observer/filing/0001688757-24-000005.json","markdown":"https://secwatch.observer/filing/0001688757-24-000005.md","text":"https://secwatch.observer/filing/0001688757-24-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000005/0001688757-24-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000005/esta-20240109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:34:54.525883+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4fb682f2a434eb08e6d9337374089cdd2545da7b","claim":"ESTABLISHMENT LABS HOLDINGS INC. reported fourth quarter and fiscal year 2023 results: revenue in the range of $31.4 million to $31.8 million. Guidance reaffirmed.","evidence_excerpt":"unaudited financial results for the fourth quarter and fiscal year 2023. Preliminary unaudited revenue for the fourth quarter of 2023 is expected to be in the range of $31.4 million to $31.8 million, in line with the guidance provided on November 7 in the third quarter earnings release. Based on the expected range for fourth quarter preliminary unaudited","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000005/0001688757-24-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and fiscal year 2023"},{"label":"Revenue","value":"in the range of $31.4 million to $31.8 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"42a9157bdbf77e7ae2a38691cbd2fbadae041a90","claim":"ESTABLISHMENT LABS HOLDINGS INC. entered into Registration Rights Agreement with the Investors (effective 2024-01-09).","evidence_excerpt":"In connection with the Private Placement, the Company entered into a registration rights agreement, dated January 9, 2024 (the “Registration Rights Agreement”), with the Investors, pursuant to which, among other things, the Company will (i) prepare and file with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-3 (or a prospectus supplement to the Company’s Form S-3 (File No. 333-271418)) to register for resale the Shares and the Common Shares issuable upon the exercise of the Pre-Funded Warrants within 30 calendar days of the closing of the Private Placement, and (ii) use commercially reasonable efforts to have the registration statement declared effective, if not automatically effective upon filing, as soon as reasonably practicable after such registration statement has been filed with the SEC.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000005/0001688757-24-000005-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the Investors"},{"label":"Effective","value":"2024-01-09"}],"fact_type":"material_agreement"},{"claim_id":"df84a6c29c0dc615e6ceccd3e7fc007209e1b751","claim":"ESTABLISHMENT LABS HOLDINGS INC. entered into Securities Purchase Agreement with select institutional accredited investors valued at approximately $50 million (effective 2024-01-09).","evidence_excerpt":"On January 9, 2024, Establishment Labs Holdings Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with select institutional accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors in a private placement (the “Private Placement”) (i) an aggregate of 1,101,565 common shares (the “Shares”) of the Company, no par value per share (the “Common Shares”), and (ii) in lieu of Common Shares, pre-funded warrants providing for the purchase, upon exercise, of an aggregate of 898,435 Common Shares (the “Pre-Funded Warrants”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000005/0001688757-24-000005-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"select institutional accredited investors"},{"label":"Value","value":"approximately $50 million"},{"label":"Effective","value":"2024-01-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}